Pharmacokinetic and Safety Study of Daclatasvir in Patients With Renal Impairment
| Status: | Completed |
|---|---|
| Conditions: | Hepatitis |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | September 2012 |
| End Date: | June 2013 |
Single Dose Pharmacokinetics and Safety of Daclatasvir in Subjects With Renal Function Impairment
The purpose of this study is to assess the effect of renal function impairment on the single
dose pharmacokinetics of Daclatasvir.
dose pharmacokinetics of Daclatasvir.
Treatment, Parallel Assignment, Open Label, Non-Randomized, Single Dose Adaptive Design,
Pharmacokinetics Study
Pharmacokinetics Study
Inclusion Criteria:
- Meet renal function criteria in one of four categories
Exclusion Criteria:
- Unstable or uncontrolled medical conditions
We found this trial at
2
sites
5055 South Orange Ave Orlando FL 32909
Orlando, Florida 32806
Orlando, Florida 32806
407-240-7878
Click here to add this to my saved trials
Click here to add this to my saved trials